Product Information
COLESEVELAM 625 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2608 per EA under NDC 68462043318. Its NADAC has been published 423 times since Jul 18, 2018.
FDA first approved this application on May 18, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
625 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462043318
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203480FDA Approved
5/18/2018
TE Code
AB
On Market Since
5/18/2018
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM 625 MG TABLET has been published 423 times since Jul 18, 2018, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2608 per EA |
|---|---|
| All-time high | $2.1506 (Aug 15, 2018) |
| All-time low | $0.1763 (Jul 17, 2024) |
| 52-week high | $0.2904 |
| 52-week low | $0.2608 |
| Median price | $0.4098 |
| Average price | $0.5782 |
| Largest weekly change | +56.2% (May 17, 2023) |
| Weeks tracked | 423 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COLESEVELAM 625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM 625 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2608 per EA (NDC 68462043318), effective Aug 19, 2026.
How has the price of COLESEVELAM 625 MG TABLET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM 625 MG TABLET has declined 87.9%. It has been tracked across 423 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for COLESEVELAM 625 MG TABLET?
Since Jul 18, 2018, the NADAC for COLESEVELAM 625 MG TABLET has ranged from a low of $0.1763 (Jul 17, 2024) to a high of $2.1506 (Aug 15, 2018), with a median of $0.4098 per EA.
Are there cheaper alternatives to COLESEVELAM 625 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as COLESEVELAM 625 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures COLESEVELAM 625 MG TABLET?
COLESEVELAM 625 MG TABLET (NDC 68462043318) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.